Rapporteur summaries of plenary, symposia, and oral sessions from the XXIIIrd World Congress of Psychiatric Genetics Meeting in Toronto, Canada, 16-20 October 2015.

Journal: Psychiatric genetics

Volume: 26

Issue: 6

Year of Publication: 2017

Affiliated Institutions:  aNeurogenetics Section bCampbell Family Mental Health Research Institute cClinical Genetics Research Program dKrembil Family Epigenetics Laboratory, Centre for Addiction and Mental Health eDepartment of Psychiatry fInstitute of Medical Science gDepartment of Psychology, University of Toronto hFrederick W. Thompson Anxiety Disorders Centre, Department of Psychiatry, Sunnybrook Health Sciences Centre iThe Dalglish Family q Clinic jUniversity Health Network kThe Centre for Applied Genomics, Genetics and Genome Biology, The Hospital for Sick Children, Toronto lMolecular Genetics Unit mBiomedical Sciences Division, Department of Biology, University of Ottawa, Ottawa, Ontario, Canada nMax Planck Institute of Psychiatry oInstitute of Psychiatric Phenomics and Genomics, University of Munich, Munich pDepartment of Translational Research in Psychiatry, Institute of Computational Biology, Helmholtz Zentrum München qDepartment of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Heidelberg rCharité Universitätsmedizin Berlin, Berlin, Germany sDepartment of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest, Hungary tSchool of Social Work uDepartment of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, Michigan vStanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, Woodbury, New York wDepartment of Psychiatry, University of Iowa, Iowa City, Iowa xVirginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, Virginia yDepartment of Chemistry and Biochemistry zDepartment of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, California, USA †Department of Nuclear Medicine, Academic Medical Centre, Amsterdam, The Netherlands ‡Institute and Department of Psychiatry, University of São Paulo Medical School, São Paulo §Department of Genetics, Instituto de Biociências ¶ADHD Outpatient Clinic, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, Brazil ∥Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden #Department of Psychiatry, University of Calabar Teaching Hospital, Calabar, Nigeria **Human Genomics Research Group, Department of Biomedicine, University of Basel, Basel, Switzerland ††Department of Psychiatry, Hakkari State Hospital, Turkey ‡‡Department of Genetics, University of Delhi, South Campus, New Delhi §§Molecular Genetics Lab, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India ¶¶Genetics Unit, IRCCS Centro S. Giovanni di Dio, Fatebenefratelli, Brescia, Italy ∥∥Queensland Brain Institute, University of Queensland, St Lucia, Queensland, Australia ##Clinic for Psychiatry, Clinical Center of Serbia, Belgrade, Serbia ***Molecular Psychiatric Laboratory, Division of Psychiatry, University College London, London, UK †††Department of Clinical Medicine, Aarhus University, Aarhus ‡‡‡Psychosis Research Unit, Aarhus University Hospital, Risskov, Denmark §§§Human Genetics Lab, Department of Genetics ¶¶¶Department of Psychiatry, Stellenbosch University, Stellenbosch, South Africa ∥∥∥Department of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece ###Nagoya University, Nagoya, Japan ****School of Psychology, Shaanxi Normal University, Xi'an, China ††††School of Psychology, National University of Ireland, Galway, Ireland.

Abstract summary 

The XXIIIrd World Congress of Psychiatric Genetics meeting, sponsored by the International Society of Psychiatric Genetics, was held in Toronto, ON, Canada, on 16-20 October 2015. Approximately 700 participants attended to discuss the latest state-of-the-art findings in this rapidly advancing and evolving field. The following report was written by trainee travel awardees. Each was assigned one session as a rapporteur. This manuscript represents the highlights and topics that were covered in the plenary sessions, symposia, and oral sessions during the conference, and contains major notable and new findings.

Authors & Co-authors:  Zai Gwyneth G Alberry Bonnie B Arloth Janine J Bánlaki Zsófia Z Bares Cristina C Boot Erik E Camilo Caroline C Chadha Kartikay K Chen Qi Q Cole Christopher B CB Cost Katherine T KT Crow Megan M Ekpor Ibene I Fischer Sascha B SB Flatau Laura L Gagliano Sarah S Kirli Umut U Kukshal Prachi P Labrie Viviane V Lang Maren M Lett Tristram A TA Maffioletti Elisabetta E Maier Robert R Mihaljevic Marina M Mittal Kirti K Monson Eric T ET O'Brien Niamh L NL Østergaard Søren D SD Ovenden Ellen E Patel Sejal S Peterson Roseann E RE Pouget Jennie G JG Rovaris Diego L DL Seaman Lauren L Shankarappa Bhagya B Tsetsos Fotis F Vereczkei Andrea A Wang Chenyao C Xulu Khethelo K Yuen Ryan K C RK Zhao Jingjing J Zai Clement C CC Kennedy James L JL

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Akiskal HS, Walker P, Puzantian VR, King D, Rosenthal TL, Dranon M. Bipolar outcome in the course of depressive illness. Phenomenologic, familial, and pharmacologic predictors. J Affect Disord. 1983;5(2):115–128.
Authors :  43
Identifiers
Doi : 
SSN : 1473-5873
Study Population
Male,Female
Mesh Terms
Genome-Wide Association Study
Other Terms
Study Design
Cross Sectional Study
Study Approach
Country of Study
Publication Country
England